Abstract
Recent years have seen an increased focus on the advancement of naturally derived products for the treatment of cancer. Since the beginning of recorded history, nature has provided a variety of medicinal agents, and an overwhelming number of drugs that we have today are derived from natural sources. Such natural agents are prominently used to treat several diseases such as diabetes, malaria, Alzheimer’s, pulmonary disorders, etc. with cancer being the highlight of this review. Due to the rapid development of resistance to chemotherapeutic drugs, the hunt for effective novel drugs is still a paramount concern in cancer treatment. Moreover, many chemotherapy drugs typically have high toxicity and adverse side effects, which necessitates the need to develop anti-tumor drugs that can be employed to treat deadly tumors with fewer negative effects on health and better efficacy. Isolation of several chemotherapeutic drugs has been conducted from a wide range of natural sources which include plants, microbes, fungi, and marine microorganisms. Considering the trends of previous decades, microbial diversity has grown to play a significant role in the formulation of pharmaceuticals and drugs, especially antibiotics and anti-cancer medications. Microbe-derived antitumor antibiotics such as anthracycline, epothilones, bleomycin, actinomycin, and staurosporine are amongst the widely used cancer chemotherapeutic agents. This review deals majorly with microbe-derived anticancer drugs taking into account their derivatives, mechanism of action, isolation procedures, limitations, and tumors targeted by them. This article also reports the phase of clinical study these drugs are undergoing. Moreover, it intends to portray the indispensable part that these microbes have been playing since time immemorial in the odyssey of chemotherapeutic agents.
Key points
• Microbial diversity contributes heavily towards the formulation of anticancer drugs.
• Polypeptides, carbohydrates, and alkaloids are prevalent microbe-based drug classes.
• Microbe-derived anticancer agents target various sarcomas, carcinomas, and lymphomas.
Graphical abstract
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdelmohsen UR, Szesny M, Othman EM, Schirmeister T, Grond S, Stopper H, Hentschel U (2012) antioxidant and anti-protease activities of diazepinomicin from the sponge-associated Micromonospora strain RV115. Mar Drugs 10:2208–2221. https://doi.org/10.3390/md10102208
Abdelmohsen UR, Bayer K, Hentschel U (2014) Diversity, abundance and natural products of marine sponge-associated actinomycetes. Nat Prod Rep 31:381–399. https://doi.org/10.1039/C3NP70111E
Abdel-Razek AS, El-Naggar ME, Allam A, Morsy OM, Othman SI (2020) Microbial natural products in drug discovery. Processes 8:470. https://doi.org/10.3390/pr8040470
Adhikari A, Teijaro CN, Townsend CA, Shen B (2020) Biosynthesis of enediyne natural products. In: Comprehensive Natural Products III, Elsevier, pp 365–414. https://doi.org/10.1016/B978-0-12-409547-2.14651-7
Ahlert J, Shepard E, Lomovskaya N, Zazopoulos E, Staffa A, Bachmann BO, Huang K, Fonstein L, Czisny A, Whitwam RE, Farnet CM, Thorson JS (2002) The calicheamicin gene cluster and its iterative type i enediyne pks. Science 297:1173–1176. https://doi.org/10.1126/science.1072105
Alihodžić S, Bukvić M, Elenkov IJ, Hutinec A, Koštrun S, Pešić D, Saxty G, Tomašković L, Žiher D (2018) Current trends in macrocyclic drug discovery and beyond -ro5. In: progress in medicinal chemistry, Elsevier, pp 113–233. https://doi.org/10.1016/bs.pmch.2018.01.002
Allred TK, Manoni F, Harran PG (2017) Exploring the boundaries of “practical”: de novo syntheses of complex natural product-based drug candidates. Chem Rev 117:11994–12051. https://doi.org/10.1021/acs.chemrev.7b00126
Altmann K-H (2001) Microtubule-stabilizing agents: a growing class of important anticancer drugs. Curr Opin Chem Biol 5:424–431. https://doi.org/10.1016/S1367-5931(00)00225-8
American Cancer Society (2021) American Cancer Society: cancer facts and figures. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2021.html. Accessed 1 December 2021
Alvarez C, Soto C, Cabezas S, Alvarado-Mesén J, Laborde R, Pazos F, Ros U, Hernández AM, Lanio ME (2021) Panorama of the intracellular molecular concert orchestrated by actinoporins, pore-forming toxins from sea anemones. Toxins 13:567. https://doi.org/10.3390/toxins13080567
Arcamone F, Penco S, Orezzi P, Nicolella V, Pirelli A (1964) Structure and Synthesis of Distamycin A. Nature 203:1064–1065. https://doi.org/10.1038/2031064a0
Arslanian RL, Tang L, Blough S, Ma W, Qiu R-G, Katz L, Carney JR (2002) A new cytotoxic epothilone from modified polyketide synthases heterologously expressed in Myxococcus x anthus. J Nat Prod 65:1061–1064. https://doi.org/10.1021/np020120f
Asai G, Yamamoto N, Toi M, Shin E, Nishiyama K, Sekine T, Nomura Y, Takashima S, Kimura M, Tominaga T (2002) Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancer. Cancer Chemother Pharmacol 49:468–472. https://doi.org/10.1007/s00280-002-0455-1
Avendaño C, Menéndez JC (2015) Anticancer drugs targeting tubulin and microtubules. In: Medicinal Chemistry of Anticancer Drugs, Elsevier, pp 359–390. https://doi.org/10.1016/b978-0-444-62649-3.00009-0
Baraldi PG, Preti D, Fruttarolo F, Tabrizi MA, Romagnoli R (2007) Hybrid molecules between distamycin A and active moieties of antitumor agents. Bioorg Med Chem 15:17–35. https://doi.org/10.1016/j.bmc.2006.07.004
Behringer K, Goergen H, Hitz F, Zijlstra JM, Greil R, Markova J, Sasse S, Fuchs M, Topp MS, Soekler M, Mathas S, Meissner J, Wilhelm M, Koch P, Lindemann H-W, Schalk E, Semrau R, Kriz J, Vieler T, Bentz M, Lange E, Mahlberg R, Hassler A, Vogelhuber M, Hahn D, Mezger J, Krause SW, Skoetz N, Böll B, von Tresckow B, Diehl V, Hallek M, Borchmann P, Stein H, Eich H, Engert A (2015) Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin’s lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial. The Lancet 385:1418–1427. https://doi.org/10.1016/S0140-6736(14)61469-0
Bertrand R, Solary E, O’Connor P, Kohn KW, Pommier Y (1994) Induction of a common pathway of apoptosis by Staurosporine. Exp Cell Res 211:314–321. https://doi.org/10.1006/excr.1994.1093
Bijur GN, De Sarno P, Jope RS (2000) Glycogen synthase kinase-3β facilitates staurosporine- and heat shock-induced apoptosis. J Biol Chem 275:7583–7590. https://doi.org/10.1074/jbc.275.11.7583
Bollag DM, McQueney PA, Zhu J, Hensens O, Koupal L, Liesch J, Goetz M, Lazarides E, Woods CM (1995) Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res 55(11):2325–2333
Bundale S, Begde D, Pillai D, Gangwani K, Nashikkar N, Kadam T, Upadhyay A (2018) Novel aromatic polyketides from soil Streptomyces spp purification, characterization and bioactivity studies. World J Microbiol Biotechnol 34:67. https://doi.org/10.1007/s11274-018-2448-1
Burgy O, Wettstein G, Bellaye PS, Decologne N, Racoeur C, Goirand F, Beltramo G, Hernandez J-F, Kenani A, Camus P, Bettaieb A, Garrido C, Bonniaud P (2016) Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicity. Sci Transl Med 8(16). https://doi.org/10.1126/scitranslmed.aad7785
Butler MS (2008) Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep 25:475. https://doi.org/10.1039/b514294f
Cao J, Huang Z, Ou S, Wen F, Yang G, Miao Q, Zhang H, Wang Y, He X, Shan Y, Liu S, Jiang L (2021) Circ0093740 promotes tumor growth and metastasis by sponging mir-136/145 and upregulating dnmt3a in wilms tumor. Front Oncol 11:647352. https://doi.org/10.3389/fonc.2021.647352
Cartuche L, Sifaoui I, Cruz D, Reyes-Batlle M, López-Arencibia A, Javier Fernández J, Díaz-Marrero AR, Piñero JE, Lorenzo-Morales J (2019) Staurosporine from Streptomyces sanyensis activates programmed cell death in Acanthamoeba via the mitochondrial pathway and presents low in vitro cytotoxicity levels in a macrophage cell line. Sci Rep 9:11651. https://doi.org/10.1038/s41598-019-48261-7
Castagnola P, Bellese G, Birocchi F, Gagliani MC, Tacchetti C, Cortese K (2016) Identification of an HSP90 modulated multi-step process for ERBB2 degradation in breast cancer cells. Oncotarget 7:85411–85429. https://doi.org/10.18632/oncotarget.13392
Chakraborty K, Kizhakkekalam VK, Joy M (2021) Macrocyclic polyketides with siderophore mode of action from marine heterotrophic Shewanella algae: prospective anti-infective leads attenuate drug-resistant pathogens. J Appl Microbiol 130:1552–1570. https://doi.org/10.1111/jam.14875
Charak S, Mehrotra R (2013) Structural investigation of idarubicin-DNA interaction: Spectroscopic and molecular docking study. Int J Biol Macromol 60:213–218. https://doi.org/10.1016/j.ijbiomac.2013.05.027
Charan RD, Schlingmann G, Janso J, Bernan V, Feng X, Carter GT (2004) Diazepinomicin, a new antimicrobial alkaloid from a marine Micromonospora sp. J Nat Prod 67:1431–1433. https://doi.org/10.1021/np040042r
Chen C, Song F, Wang Q, Abdel-Mageed WM, Guo H, Fu C, Hou W, Dai H, Liu X, Yang N, **e F, Yu K, Chen R, Zhang L (2012) A marine-derived Streptomyces sp. MS449 produces high yield of actinomycin X2 and actinomycin D with potent anti-tuberculosis activity. Appl Microbiol Biotechnol 95:919–927. https://doi.org/10.1007/s00253-012-4079-z
Chen Y, Liu J, Yuan B, Cao C, Qin S, Cao X, Bian G, Wang Z, Jiang J (2013) Methylated actinomycin D, a novel actinomycin D analog induces apoptosis in HepG2 cells through Fas- and mitochondria-mediated pathways. Mol Carcinog 52:983–996. https://doi.org/10.1002/mc.21943
Cheng J, Park SB, Kim SH, Yang SH, Suh J-W, Lee CH, Kim JG (2016) Suppressing activity of staurosporine from Streptomyces sp. MJM4426 against rice bacterial blight disease. J Appl Microbiol 120:975–985. https://doi.org/10.1111/jam.13034
Chiba S, Sakata-Yanagimoto M (2020) Advances in understanding of angioimmunoblastic T-cell lymphoma. Leukemia 34:2592–2606. https://doi.org/10.1038/s41375-020-0990-y
Choi A, Kang YK, Lim S, Kim DH, Lim JS, Lee JA (2016) Severe hepatic sinusoidal obstruction syndrome in a child receiving vincristine, actinomycin-D, and cyclophosphamide for rhabdomyosarcoma: successful treatment with defibrotide. Cancer Res Treat 48:1443–1447. https://doi.org/10.4143/crt.2016.096
Cooper GM, Hausman RE (2016) The cell: a molecular approach, Seventh Edition. Yale J Biol Med 89(3):424
Dains-McGahee C, Friedman E, Graves S, Sabbatini M (2015) Ac3 has an inhibitory effect on cell cycle and enhances staurosporine-induced apoptosis in pancreatic cancer cells: participation of R-Smads. http://hdl.handle.net/10675.2/565786
Dalal P, Sharma D (2021) Microbe defines the efficacy of chemotherapeutic drug: a complete paradigm. FEMS Microbiol Lett 368(17):116. https://doi.org/10.1093/femsle/fnab116
Daniel SK, Seo YD, Pillarisetty VG (2020) The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies. Semin Cancer Biol 65:176–188. https://doi.org/10.1016/j.semcancer.2019.12.007
De Vries JF, Zwaan CM, De Bie M, Voerman JSA, den Boer ML, van Dongen JJM, van der Velden VHJ (2012) The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells. Leukemia 26:255–264. https://doi.org/10.1038/leu.2011.206
Demain AL (2014) Importance of microbial natural products and the need to revitalize their discovery. J Ind Microbiol Biotechnol 41:185–201. https://doi.org/10.1007/s10295-013-1325-z
Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, Simon RH (1996) Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97:232–237. https://doi.org/10.1172/JCI118396
Falini B, Brunetti L, Martelli MP (2015) Dactinomycin in npm1 -mutated acute myeloid leukemia. N Engl J Med 373:1180–1182. https://doi.org/10.1056/NEJMc1509584
Forli S (2014) Epothilones: from discovery to clinical trials. Curr Top Med Chem 14:2312–2321. https://doi.org/10.2174/1568026614666141130095855
Gandhi R, Khatri N, Baradia D, Vhora I, Misra A (2016) Surface-modified Epirubicin-HCl liposomes and its in vitro assessment in breast cancer cell-line: MCF-7. Drug Deliv 23:1152–1162. https://doi.org/10.3109/10717544.2014.999960
Gerber H-P, Damelin M, Sapra P (2017) Calicheamicin antibody-drug conjugates for liquid and solid tumor indications. In: Grawunder U, Barth S (eds) Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins. Springer International Publishing, Cham, pp 69–84
Goodin S, Kane MP, Rubin EH (2004) Epothilones: mechanism of action and biologic activity. JCO 22:2015–2025. https://doi.org/10.1200/JCO.2004.12.001
Gozari M, Alborz M, El-Seedi HR, Jassbi AR (2021) Chemistry, biosynthesis and biological activity of terpenoids and meroterpenoids in bacteria and fungi isolated from different marine habitats. Eur J Med Chem 210:112957. https://doi.org/10.1016/j.ejmech.2020.112957
Grehn L, Ragnarsson U (1981) Novel efficient total synthesis of antiviral antibiotic distamycin A. J Org Chem 46:3492–3497. https://doi.org/10.1021/jo00330a022
Groselj A, Krzan M, Kosjek T, Bosnjak M, Sersa G, Cemazar M (2016) Bleomycin pharmacokinetics of bolus bleomycin dose in elderly cancer patients treated with electrochemotherapy. Cancer Chemother Pharmacol 77:939–947. https://doi.org/10.1007/s00280-016-3004-z
Gu J, Codd R (2015) The resolution of two clinical agents, bleomycin and desferrioxamine B, from a Streptomyces verticillus fermentation mixture using multi-dimensional immobilised metal ion affinity chromatography. RSC Adv 5:3443–3453. https://doi.org/10.1039/C4RA09315A
Guffroy M, Falahatpisheh H, Biddle K, Kreeger J, Obert L, Walters K, Goldstein R, Boucher G, Coskran T, Reagan W, Sullivan D, Huang C, Sokolowski S, Giovanelli R, Gerber H-P, Finkelstein M, Khan N (2017) Liver microvascular injury and thrombocytopenia of antibody–calicheamicin conjugates in cynomolgus monkeys—mechanism and monitoring. Clin Cancer Res 23:1760–1770. https://doi.org/10.1158/1078-0432.CCR-16-0939
Hassan SS, ul, Anjum K, Abbas SQ, Akhter N, Shagufta BI, Shah SAA, Tasneem U, (2017) Emerging biopharmaceuticals from mar actinobacteria. Environ Toxicol Pharmacol 49:34–47. https://doi.org/10.1016/j.etap.2016.11.015
He D-L, ** R-Y, Li H-Z, Liu Q-Y, Zhang Z-J (2018) Identification of a novel anticancer oligopeptide from perilla frutescens (L.) britt. And its enhanced anticancer effect by targeted nanoparticles in vitro. Int J Polm Sci 2018:1–8. https://doi.org/10.1155/2018/1782734
Heisey RM, Putnam AR (1986) Herbicidal Effects of Geldanamycin and Nigericin, Antibiotics from Streptomyces hygroscopicus. J Nat Prod 49:859–865. https://doi.org/10.1021/np50047a016
Hill CR, Cole M, Errington J, Malik G, Boddy AV, Veal GJ (2014) Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer. Clin Pharmacokinet 53:741–751. https://doi.org/10.1007/s40262-014-0153-2
Hong Y-S, Lee D, Kim W, Jeong J-K, Kim C-G, Sohng JK, Lee J-H, Paik S-G, Lee JJ (2004) Inactivation of the carbamoyltransferase gene refines post-polyketide synthase modification steps in the biosynthesis of the antitumor agent geldanamycin. J Am Chem Soc 126:11142–11143. https://doi.org/10.1021/ja047769m
Hortobágyi GN (1997) Anthrazykline in der Krebstherapie: Ein Überblick. Drugs 54:1–7. https://doi.org/10.2165/00003495-199700544-00003
Hossain F, Andreana PR (2019) Developments in Carbohydrate-Based Cancer Therapeutics Pharmaceuticals 12:84. https://doi.org/10.3390/ph12020084
Hou M-H, Robinson H, Gao YG, Wang AHJ (2002) Crystal structure of actinomycin D bound to the CTG triplet repeat sequences linked to neurological diseases. Nucleic Acids Res 30:4910–4917. https://doi.org/10.1093/nar/gkf619
Huang X (2020) Abstract 4571: Development of glycoconjugate based anticancer immunotherapy. In: Immunology. American Association for Cancer Research, pp 4571–4571
Iwata S, Katoh Y, Kawai A (2020) Sarcoma. Japanese J Cancer Chemother. https://doi.org/10.5005/jp/books/12587_42
Jacobsen MD, Weil M, Raff MC (1996) Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J Cell Biol 133:1041–1051. https://doi.org/10.1083/jcb.133.5.1041
Jimenez PC, Wilke DV, Ferreira EG, Takeara R, de Moraes MO, Silveira ER, da Cruz Lotufo TM, Lopes NP, Costa-Lotufo LV (2012) Structure elucidation and anticancer activity of 7-oxostaurosporine derivatives from the brazilian Endemic Tunicate Eudistoma vannamei. Mar Drugs 10:1092–1102. https://doi.org/10.3390/md10051092
Jurczyszyn A, Zebzda A, Czepiel J, Perucki W, Bazan-Socha S, Cibor D, Owczarek D, Majka M (2014) Geldanamycin and its derivatives inhibit the growth of myeloma cells and reduce the expression of the MET receptor. J Cancer 5:480–490. https://doi.org/10.7150/jca.8731
Kalyanaraman B (2020) Teaching the basics of the mechanism of doxorubicin-induced cardiotoxicity: have we been barking up the wrong tree? Redox Biol 29:101394. https://doi.org/10.1016/j.redox.2019.101394
Khadrawy YA, Hosny EN, Mohammed HS (2021) Protective effect of nanocurcumin against neurotoxicity induced by doxorubicin in rat’s brain. Neurotoxicology 85:1–9. https://doi.org/10.1016/j.neuro.2021.04.003
Khalifa SAM, Elias N, Farag MA, Chen L, Saeed A, Hegazy M-EF, Moustafa MS, El-Wahed AA, Al-Mousawi SM, Musharraf SG, Chang F-R, Iwasaki A, Suenaga K, Alajlani M, Göransson U, El-Seedi HR (2019) Marine natural products: a source of novel anticancer drugs. Mar Drugs 17:491. https://doi.org/10.3390/md17090491
Khazir J, Riley DL, Pilcher LA, De-Maayer P, Mir BA (2014) Anticancer agents from diverse natural sources. Nat Prod Comm 9:1934578X1400901130. https://doi.org/10.1177/1934578X1400901130
Kim WJ, Kim YO, Kim JH, Nam B-H, Kim D-G, An CM, Lee JS, Kim PS, Lee HM, Oh J-S, Lee JS (2016) Liquid chromatography-mass spectrometry-based rapid secondary-metabolite profiling of marine Pseudoalteromonas sp. M2. Marine Drugs 14:24. https://doi.org/10.3390/md14010024
Kowalski RJ, Giannakakou P, Hamel E (1997) Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to Paclitaxel (Taxol®). J Biol Chem 272:2534–2541. https://doi.org/10.1074/jbc.272.4.2534
Kulkarni JA, Witzigmann D, Thomson SB, Chen S, Leavitt BR, Cullis PR, van der Meel R (2021) The current landscape of nucleic acid therapeutics. Nat Nanotechnol 16:630–643. https://doi.org/10.1038/s41565-021-00898-0
Kuncharoen N, Fukasawa W, Iwatsuki M, Mori M, Shiomi K, Tanasupawat S (2019) Characterisation of two polyketides from Streptomyces sp. SKH1-2 isolated from roots of Musa (ABB) cv. ‘Kluai Sao Kratuep Ho.’ Int Microbiol 22:451–459. https://doi.org/10.1007/s10123-019-00071-7
Li D, Liu J, Wang X, Kong D, Du W, Li H, Hse C-Y, Shupe T, Zhou D, Zhao K (2018) Biological potential and mechanism of prodigiosin from Serratia marcescens Subsp lawsoniana in human choriocarcinoma and prostate cancer cell lines. Int J Med Stud 19:3465. https://doi.org/10.3390/ijms19113465
Lien W, Chen T, Sheu S, Lin T, Kang F, Yu C, Kuan T, Huang B, Wang C (2018) 7-hydroxy-staurosporine, UCN-01, induces DNA damage response, and autophagy in human osteosarcoma U2-OS cells. J Cell Biochem 119:4729–4741. https://doi.org/10.1002/jcb.26652
Liu XF, **ang L, Zhou Q, Carralot J-P, Prunotto M, Niederfellner G, Pastan I (2016) Actinomycin D enhances killing of cancer cells by immunotoxin RG7787 through activation of the extrinsic pathway of apoptosis. Proc Natl Acad Sci USA 113:10666–10671. https://doi.org/10.1073/pnas.1611481113
Liu S, Chen D, Horowitz J (2018) Myocardial toxicity of doxorubicin compared with that of hydrogen peroxide and peroxynitrite: results from flow cytometric analyses. Heart Lung Cir 27:S114. https://doi.org/10.1016/j.hlc.2018.06.159
Lopes C, Pereira C, Medeiros R (2021) Asct2 and lat1 contribution to the hallmarks of cancer: from a molecular perspective to clinical translation. Cancers 13:203. https://doi.org/10.3390/cancers13020203
Lu X-J, Du N, Zhang D-B, Zhou X-X, Li X-F, Ju J-H, Hu Z-L, Wang L-Y (2021) Efficient, green, and rapid strategy for separating actinomycin D and X2 using supercritical fluid chromatography. J Pharm Biomed Anal 195:113835. https://doi.org/10.1016/j.jpba.2020.113835
Łukasiewicz K, Fol M (2018) Microorganisms in the treatment of cancer: advantages and limitations. J Immunol Res 2018:1–8. https://doi.org/10.1155/2018/2397808
Lunkad R, Murmiliuk A, Hebbeker P, Boublík M, Tošner Z, Štěpánek M, Košovan P (2021) Quantitative prediction of charge regulation in oligopeptides. Mol Syst Des Eng 6:122–131. https://doi.org/10.1039/D0ME00147C
Mabjeesh NJ, Post DE, Willard MT, Kaur B, Meir EGV, Simons JW, Zhong H (2002) Geldanamycin induces degradation of hypoxia-inducible factor 1α protein via the proteosome pathway in prostate cancer cells. Cancer Res 62:2478–2482
Mahalingam D, Sankhala K, Mita A, Giles FJ, Mita MM (2009) Targeting the mTOR pathway using deforolimus in cancer therapy. Future Oncol 5:291–303. https://doi.org/10.2217/fon.09.9
Malsy M, Bitzinger D, Graf B, Bundscherer A (2019) Staurosporine induces apoptosis in pancreatic carcinoma cells PaTu 8988t and Panc-1 via the intrinsic signaling pathway. Eur J Med Res 24:5. https://doi.org/10.1186/s40001-019-0365-x
Martins-Teixeira MB, Carvalho I (2020) Antitumour anthracyclines: progress and perspectives. ChemMedChem 15:933–948. https://doi.org/10.1002/cmdc.202000131
Marverti G, Guaitoli G, Ligabue A, Frassineti C, Monti MG, Lombardi P, Costi MP (2012) Distamycin A and derivatives as synergic drugs in cisplatin-sensitive and -resistant ovarian cancer cells. Amino Acids 42:641–653. https://doi.org/10.1007/s00726-011-1039-3
Matthew S, Schupp PJ, Luesch H (2008) Apratoxin E, a cytotoxic peptolide from a guamanian collection of the marine Cyanobacterium Lyngbya bouillonii. J Nat Prod 71:1113–1116. https://doi.org/10.1021/np700717s
McDonald GB, Freston JW, Boyer JL, DeLeve LD (2019) Liver complications following treatment of hematologic malignancy with Anti-CD22-Calicheamicin (Inotuzumab Ozogamicin). Hepatology 69:831–844. https://doi.org/10.1002/hep.30222
McSorley FR, Johnson JW, Wright GD (2018) Natural products in antibiotic discovery. In: Fong IW, Shlaes D, Drlica K (eds) Antimicrobial Resistance in the 21st Century. Springer International Publishing, pp 533–562
Molnár I, Schupp T, Ono M, Zirkle R, Milnamow M, Nowak-Thompson B, Engel N, Toupet C, Stratmann A, Cyr D, Gorlach J, Mayo J, Hu A, Goff S, Schmid J, Ligon J (2000) The biosynthetic gene cluster for the microtubule-stabilizing agents epothilones A and B from Sorangium cellulosum So ce90. Chem Biol 7:97–109. https://doi.org/10.1016/S1074-5521(00)00075-2
Mondal A, Gandhi A, Fimognari C, Atanasov AG, Bishayee A (2019) Alkaloids for cancer prevention and therapy: current progress and future perspectives. Eur J Pharm 858:172472. https://doi.org/10.1016/j.ejphar.2019.172472
Murray SA, Murray SA (2017) Study on the structural relationship between bleomycin analogs and DNA hairpins, A. Dissertation, University of Wyoming. Libraries. https://hdl.handle.net/20.500.11919/1433
Nakano I, Soe CZ, Codd R (2015) Isolation of doxorubicin from a bacterial culture using immobilised metal ion affinity chromatography. RSC Adv 5:46437–46442. https://doi.org/10.1039/C5RA07639K
Neidle S (2008) Cancer Drug Design and Discovery. Elsevier. https://doi.org/10.1016/B978-0-12-369448-5.X5001-0
Neumeister P, Eibl M, Zinke-Cerwenka W, Scarpatetti M, Sill H, Linkesch W (2001) Hepatic veno-occlusive disease in two patients with relapsed acute myeloid leukemia treated with anti-CD33 calicheamicin (CMA-676) immunoconjugate. Ann Hematol 80:119–120. https://doi.org/10.1007/s002770000239
Newman DJ (2016) Predominately uncultured microbes as sources of bioactive agents. Front Microbiol 7. https://doi.org/10.3389/fmicb.2016.01832
Newman DJ, Cragg GM (2016) Natural Products as Sources of New Drugs from 1981 to 2014. J Nat Prod 79:629–661. https://doi.org/10.1021/acs.jnatprod.5b01055
Nicolay NH, Rühle A, Perez RL, Trinh T, Sisombath S, Weber K-J, Ho AD, Debus J, Saffrich R, Huber PE (2016) Mesenchymal stem cells are sensitive to bleomycin treatment. Sci Rep 6:26645. https://doi.org/10.1038/srep26645
Nimmanapalli R, O’Bryan E, Bhalla K (2001) Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts. Cancer Res 61:1799–1804
Okuno S, Maples WJ, Mahoney MR, Fitch T, Stewart J, Fracasso PM, Kraut M, Ettinger DS, Dawkins F, Erlichman C (2005) Evaluation of epothilone B analog in advanced soft tissue sarcoma: a phase II study of the phase II consortium. JCO 23:3069–3073. https://doi.org/10.1200/JCO.2005.00.372
Omura S, Iwai Y, Hirano A, Nakagawa A, Awaya J, Tsuchiya H, Takahashi Y, Asuma R (1977) A new alkaloid AM-2282 of Streptomyces origin taxonomy, fermentation, isolation and preliminary characterization. J Antibiot 30:275–282. https://doi.org/10.7164/antibiotics.30.275
Ōmura S, Asami Y, Crump A (2018) Staurosporine: new lease of life for parent compound of today’s novel and highly successful anti-cancer drugs. J Antibiot 71:688–701. https://doi.org/10.1038/s41429-018-0029-z
Önder A (2020) Anticancer activity of natural coumarins for biological targets. In: Studies in Natural Products Chemistry. Elsevier, pp 85–109. https://doi.org/10.1016/B978-0-12-817903-1.00003-6
Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100:8407–8411. https://doi.org/10.1073/pnas.1432929100
Osathanondh R, Goldstein DP, Pastorfide GB (1975) Actinomycin D as the primary agent for gestational trophoblastic disease. Cancer 36:863–866. https://doi.org/10.1002/1097-0142(197509)36:3%3c863::AID-CNCR2820360306%3e3.0.CO;2-G
Otles S, Özyurt VH (2021) Biotransformation in the production of secondary metabolites. In: Studies in Natural Products Chemistry, Elsevier, pp 435–457. https://doi.org/10.1016/B978-0-12-819485-0.00007-4
Patil Y, Amitay Y, Ohana P, Shmeeda H, Gabizon A (2016) Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: intracellular activation and enhanced cytotoxicity. J Control Release 225:87–95. https://doi.org/10.1016/j.jconrel.2016.01.039
Pedersen KS, Kim GP, Foster NR, Wang-Gillam A, Erlichman C, McWilliams RR (2015) Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic phase II consortium study. Invest New Drugs 33:963–968. https://doi.org/10.1007/s10637-015-0246-2
Peng Y, Wang Y, Wang X (2020) Exploring the thermodynamics of 7-amino actinomycin D-induced single-stranded DNA hairpin by spectroscopic techniques and computational simulations. J Phys Chem B. https://doi.org/10.1021/acs.jpcb.0c05593
Pham JV, Yilma MA, Feliz A, Majid MT, Maffetone N, Walker JR, Kim E, Cho HJ, Reynolds JM, Song MC, Park SR, Yoon YJ (2019) A review of the microbial production of bioactive natural products and biologics. Front Microbiol 10:1404. https://doi.org/10.3389/fmicb.2019.01404
Piel J (2011) Approaches to capturing and designing biologically active small molecules produced by uncultured microbes. Annu Rev Microbiol 65:431–453. https://doi.org/10.1146/annurev-micro-090110-102805
Pillai G (2019) Nanotechnology toward treating cancer: A comprehensive review. In: Applications of Targeted Nano Drugs and Delivery Systems. Elsevier Inc. pp 221–256. https://doi.org/10.1016/b978-0-12-814029-1.00009-0
Pillai G, Ceballos-Coronel ML (2013) Science and technology of the emerging nanomedicines in cancer therapy: a primer for physicians and pharmacists. SAGE Open Med 1:205031211351375. https://doi.org/10.1177/2050312113513759
Pooja D, Kadari A, Kulhari H, Sistla R (2018) Lipid-based nanomedicines: Current clinical status and future perspectives, Lipid Nanocarriers for Drug Targeting. Chapter 13. Elsevier Inc. https://doi.org/10.1016/B978-0-12-813687-4.00013-X
Portugal J (2003) Chartreusin, elsamicin A and related anti-cancer antibiotics. Curr Med Chem - Anti-Cancer Agents 3(6):411–420. https://doi.org/10.2174/1568011033482215
Possati L, Campioni D, Sola F, Leone L, Ferrante L, Trabanelli C, Ciomei M, Montesi M, Rocchetti R, Talevi S, Bompadre S, Caputo A, Barbanti-Brodano G, Corallini A (1999) Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi’s sarcoma- like murine model. Clin Exp Metastasis 17:575–582. https://doi.org/10.1023/A:1006737029616
Prasanna PL, Renu K, Valsala Gopalakrishnan A (2020) New molecular and biochemical insights of doxorubicin-induced hepatotoxicity. Life Sci 250:117599. https://doi.org/10.1016/j.lfs.2020.117599
Priya S, Satheeshkumar PK (2020) Natural products from plants. In: Functional and Preservative Properties of Phytochemicals, Elsevier, pp 145–163. https://doi.org/10.1016/B978-0-12-818593-3.00005-1
Puri M, Sharma D, Barrow CJ (2012) Enzyme-assisted extraction of bioactives from plants. Trends Biotechnol 30:37–44. https://doi.org/10.1016/j.tibtech.2011.06.014
Qi X, Wang X, Ren H, Zhang F, Zhang X, He N, Guo W, Chen R, **e Y, He Q (2017) NC1404, a novel derivative of Bleomycin with modified sugar moiety obtained uring the preparation of Boningmycin. J Antibiot (tokyo). https://doi.org/10.1038/ja.2017.63
Qin Y, Guo T, Wang Z, Zhao Y (2021) The role of iron in doxorubicin-induced cardiotoxicity: recent advances and implication for drug delivery. J Mater Chem B. https://doi.org/10.1039/d1tb00551k
Rambabu V, Vijayakumar S (2014) In vitro cytotoxicity perspective of diazepinomicin (ECO-4601) on human hepatoma cell line (HEPG2). Biomed Aging Pathol 4:65–70. https://doi.org/10.1016/j.biomag.2013.10.004
Rasti B, Shahangian SS (2019) In-silico analysis of chemical space governing the interactions between distamycin a derivatives and DNA molecule. Modares J Biotechnol 10(1):69–75. http://biot.modares.ac.ir/article-22-13366-en.html
Ricart AD (2011) Antibody-drug conjugates of calicheamicin derivative: gemtuzumab ozogamicin and inotuzumab ozogamicin. Clin Cancer Res 17(20):6417–6427. https://doi.org/10.1158/1078-0432.CCR-11-0486
Rivankar S (2014) An overview of doxorubicin formulations in cancer therapy. J Can Res Ther 10:853. https://doi.org/10.4103/0973-1482.139267
Rivkin A, Yoshimura F, Gabarda AE, Cho YS, Chou TC, Dong H, Danishefsky SJ (2004) Discovery of (E)-9,10-dehydroepothilones through chemical synthesis: On the emergence of 26-trifluoro-(E)-9,10-dehydro-12,13-desoxyepothilone B as a promising anticancer drug candidate. J Am Chem Soc 126:10913–10922. https://doi.org/10.1021/ja046992g
Rogalska A, Marczak A, Gajek A, Szwed M, Śliwińska A, Drzewoski J, Jóźwiak Z (2013) Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B. Toxicol in Vitro 27:239–249. https://doi.org/10.1016/j.tiv.2012.09.006
Salas S, Chakraborty K (2020) Polyether macrocyclic polyketide from the muricid gastropod Chicoreus ramosus attenuates pro-inflammatory 5-lipoxygenase. Med Chem Res 29:1976–1985. https://doi.org/10.1007/s00044-020-02614-4
Samanta D, Semenza GL (2018) Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors. Biochimica et Biophysica Acta (BBA) - Rev Cancer 1870:15–22. https://doi.org/10.1016/j.bbcan.2018.07.002
Sano M (2001) Radicicol and geldanamycin prevent neurotoxic effects of anti-cancer drugs on cultured embryonic sensory neurons. Neuropharmacology 40:947–953. https://doi.org/10.1016/S0028-3908(01)00018-1
Sedighi M, Zahedi Bialvaei A, Hamblin MR, Ohadi E, Asadi A, Halajzadeh M, Lohrasbi V, Mohammadzadeh N, Amiriani T, Krutova M, Amini A, Kouhsari E (2019) Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities. Cancer Med 8(6):3167–3181. https://doi.org/10.1002/cam4.2148 (cam4.2148)
Seeberger PH (2021) Discovery of semi- and fully-synthetic carbohydrate vaccines against bacterial infections using a medicinal chemistry approach: focus review. Chem Rev 121:3598–3626. https://doi.org/10.1021/acs.chemrev.0c01210
Sharma V, Sinha PK, Singh J, Sinha ES (2021) Role of microbes and microbial products in cancer therapeutics. In: Arora PK (ed) Microbial Products for Health, Environment and Agriculture. Springer Singapore, Singapore, pp 203–220
Shen B, Du L, Sanchez C, Edwards DJ, Chen M, Murrell JM (2001) The biosynthetic gene cluster for the anticancer drug bleomycin from Streptomyces verticillus ATCC15003 as a model for hybrid peptide-polyketide natural product biosynthesis. J Ind Microbiol Biotechnol 27:378–385. https://doi.org/10.1038/sj.jim.7000194
Shende P, Basarkar V (2019) Recent trends and advances in microbe-based drug delivery systems. DARU J Pharm Sci 27:799–809. https://doi.org/10.1007/s40199-019-00291-2
Shetty PR, Buddana SK, Tatipamula VB, Naga YVV, Ahmad J (2014) Production of polypeptide antibiotic from Streptomyces parvulus and its antibacterial activity. Braz J Microbiol 45:303–312. https://doi.org/10.1590/S1517-83822014005000022
Siboni RB, Nakamori M, Wagner SD, Struck AJ, Coonrod LA, Harriott SA, Cass DM, Tanner MK, Berglund JA (2015) Actinomycin D specifically reduces expanded CUG repeat RNA in myotonic dystrophy models. Cell Rep 13:2386–2394. https://doi.org/10.1016/j.celrep.2015.11.028
Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer Statistics, 2021. CA A Cancer J Clin 71:7–33. https://doi.org/10.3322/caac.21654
Sievers EL, Appelbaum FR, Spielberger RT, Forman SJ, Flowers D, Smith FO, Shannon-Dorcy K, Berger MS, Bernstein ID (1999) Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate. Blood 93:3678–3684
Singal PK, Iliskovic N (1998) Doxorubicin-induced cardiomyopathy. N Engl J Med 339:900–905. https://doi.org/10.1056/NEJM199809243391307
Sissi C, Moro S, Crothers DM (2015) Novel insights on the DNA interaction of calicheamicin γ 1 I: Calicheamicin γ I 1 -DNA Interaction. Biopolymers 103:449–459. https://doi.org/10.1002/bip.22591
Sittler A (2001) Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington’s disease. Hum Mol Genet 10:1307–1315. https://doi.org/10.1093/hmg/10.12.1307
Sun J, Prabhu N, Tang J, Yang F, Jia L, Guo J, **ao K, Tam WL, Nordlund P, Dai L (2021) Recent advances in proteome-wide label-free target deconvolution for bioactive small molecules. Med Res Rev 41:2893–2926. https://doi.org/10.1002/med.21788
Taechowisan T, Puckdee W, Waratchareeyakul W, Phutdhawong WS (2020) Anti-Inflammatory activity of geldanamycin and its derivatives in LPS-Induced RAW 264.7 cells. Adv Appl Microbiol 9(4):398–421. https://doi.org/10.4236/aim.2019.94024
Taechowisan T, Wanbanjob A, Tuntiwachwuttikul P, Taylor WC (2006) Identification of Streptomyces sp. Tc022, an endophyte inAlpinia galanga, and the isolation of actinomycin D. Ann Microbiol 56:113–117. https://doi.org/10.1007/BF03174991
Terry J, Lubieniecka JM, Kwan W, Liu S, Nielsen TO (2005) Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin prevents synovial sarcoma proliferation via apoptosis in in vitro models. Clin Cancer Res 11:5631–5638. https://doi.org/10.1158/1078-0432.CCR-05-0398
Tewari D, Rawat P, Singh PK (2019) Adverse drug reactions of anticancer drugs derived from natural sources. Food Chem Toxicol 123:522–535. https://doi.org/10.1016/j.fct.2018.11.041
Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, Klein TE, Altman RB (2011) Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genom 21:440–446. https://doi.org/10.1097/FPC.0b013e32833ffb56
Thorson JS, Sievers, Ahlert J, Shepard E, Whitwam RE, Onwueme KC, Ruppen M (2000) Understanding and exploiting nature’s chemical arsenal: the past, present and future of calicheamicin research. Bentham Science Publishers pp. 1841–1879. https://doi.org/10.2174/1381612003398564
Thuan NH, Dhakal D, Pokhrel AR, Chu LL, Van Pham TT, Shrestha A, Sohng JK (2018) Genome-guided exploration of metabolic features of Streptomyces peucetius ATCC 27952: past, current, and prospect. Appl Microbiol Biotechnol 102:4355–4370. https://doi.org/10.1007/s00253-018-8957-x
Timur M, Cort A, Ozdemir E, Sarikcioglu S, Sanlioglu S, Sanlioglu A, Ozben T (2015) Bleomycin induced sensitivity to TRAIL/Apo-2L-mediated apoptosis in human seminomatous testicular cancer cells is correlated with upregulation of death receptors. Anticancer Agents Med Chem 15:99–106. https://doi.org/10.2174/1871520614666140829130047
Tran DB, AlAshi AK, Hernandez A (2021) Delayed onset anthracycline-associated cardiotoxicity presenting as acute decompensated heart failure seven years after chemotherapy completion. Cureus. https://doi.org/10.7759/cureus.16920
Tzaridis T, Milde T, Pajtler KW, Bender S, Jones DTW, Müller S, Wittmann A, Schlotter M, Kulozik AE, Lichter P, Collins VP, Witt O, Kool M, Korshunov A, Pfister SM, Witt H (2016) Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA -positive ependymoma. Oncotarget 7:61860–61873. https://doi.org/10.18632/oncotarget.11452
Ueberschaar N, Xu Z, Scherlach K, Metsä-Ketelä M, Bretschneider T, Dahse H-M, Görls H, Hertweck C (2013) Synthetic remodeling of the chartreusin pathway to tune antiproliferative and antibacterial activities. J Am Chem Soc 135:17408–17416. https://doi.org/10.1021/ja4080024
Ueberschaar N, Meyer F, Dahse H-M, Hertweck C (2016) Bipiperidine conjugates as soluble sugar surrogates in DNA-intercalating antiproliferative polyketides. Chem Commun 52:4894–4897. https://doi.org/10.1039/C6CC00890A
Viegelmann C, Margassery LM, Kennedy J, Zhang T, O’Brien C, O’Gara F, Morrissey JP, Dobson ADW, Edrada-Ebel R (2014) Metabolomic profiling and genomic study of a marine sponge-associated Streptomyces sp. Mar Drugs 12:3323–3351. https://doi.org/10.3390/md12063323
Vigevani A, Williamson MJ (1980) Doxorubicin. In: Florey K (ed) Analytical profiles of drug substances, vol 9. Academic Press, CA, pp 245–273
Vingadassalon A, Lorieux F, Juguet M, Le Goff G, Gerbaud C, Pernodet J-L, Lautru S (2015) Natural combinatorial biosynthesis involving two clusters for the synthesis of three pyrrolamides in Streptomyces netropsis. ACS Chem Biol 10:601–610. https://doi.org/10.1021/cb500652n
Volpe DA, Du D-L, Zurlo MG, Mongelli N, Murphy MJ (1992) Comparativein vitro myelotoxicity of FCE 24517, a distamycin derivative, to human, canine and murine hematopoietic progenitor cells. Invest New Drugs 10:255–261. https://doi.org/10.1007/BF00944178
Washington AZ, Benicewicz DB, Canzoneri JC, Fagan CE, Mwakwari SC, Maehigashi T, Dunham CM, Oyelere AK (2014) Macrolide-peptide conjugates as probes of the path of travel of the nascent peptides through the ribosome. ACS Chem Biol 9:2621–2631. https://doi.org/10.1021/cb5003224
Woods LM, Arico JW, Frein JD, Sackett DL, Taylor RE (2017) Synthesis and biological evaluation of 7-deoxy-epothilone analogues. Int J Mol Sci 18:1–14. https://doi.org/10.3390/ijms18030648
Wrodnigg T (2004) Bioactive carbohydrates and recently discovered analogues as chemotherapeutics. Med Chem 4(4). https://doi.org/10.2174/1389557043403918
Wu Z-C, Boger DL (2020) The quest for supernatural products: the impact of total synthesis in complex natural products medicinal chemistry. Nat Prod Rep 37:1511–1531. https://doi.org/10.1039/D0NP00060D
Xu Z, Jakobi K, Welzel K, Hertweck C (2005) Biosynthesis of the antitumor agent chartreusin involves the oxidative rearrangement of an anthracyclic polyketide. Chem Biol 12:579–588. https://doi.org/10.1016/j.chembiol.2005.04.017
Yagi M, Nishimura T, Suzuki H, Tanaka N (1981) Chartreusin, an antitumor glycoside antibiotic, induces DNA strand scission. Biochem Biophys Res Commun 98:642–647. https://doi.org/10.1016/0006-291X(81)91162-1
Yagi A, Uchida R, Kobayashi K, Tomoda H (2020) Polyketide glycosides phialotides A to H, new potentiators of amphotericin B activity, produced by Pseudophialophora sp. BF-0158. J Antibiot 73:211–223. https://doi.org/10.1038/s41429-019-0276-7
Yang, CL, Wang, YS, Liu CL, Zeng YJ, Cheng P, Jiao RH, Bao SX, Huang HQ, Tan RX, Ge HM (2017) Strepchazolins A and B: Two new alkaloids from a marine Streptomyces chartreusis NA02069. Mar Drugs 15. https://doi.org/10.3390/md15080244
Yang H, Zhang Z, Tang W, Ren L, Wang D, Sun F, Zheng W (2015) Preparative isolation and purification of epothilones from Sorangium cellulosum fermentation broth by high-speed counter-current chromatography. J Liq Chromatogr Relat Technol 38:123–127. https://doi.org/10.1080/10826076.2014.883541
Yurkiewicz, IR, Muffly L, Liedtke M (2018) Inotuzumab ozogamicin: a CD22 mab–drug conjugate for adult relapsed or refractory b-cell precursor acute lymphoblastic leukemia. Drug Des Devel Ther Dovepress, pp 2293–2300. https://doi.org/10.2147/DDDT.S150317
Zaffaroni N, Lualdi S, Villa R, Bellarosa D, Cermele C, Felicetti P, Rossi C, Orlandi L, Daidone MG (2002) Inhibition of telomerase activity by a distamycin derivative: Effects on cell proliferation and induction of apoptosis in human cancer cells. Eur J Cancer 38:1792–1801. https://doi.org/10.1016/S0959-8049(02)00139-9
Zhang J, Kinoh H, Hespel L, Liu X, Quader S, Martin J, Chida T, Cabral H, Kataoka K (2017) Effective treatment of drug resistant recurrent breast tumors harboring cancer stem-like cells by staurosporine/epirubicin co-loaded polymeric micelles. J Control Release 264:127–135. https://doi.org/10.1016/j.jconrel.2017.08.025
Zhang J-M, Wang H-H, Liu X, Hu C-H, Zou Y (2020) Heterologous and engineered biosynthesis of nematocidal polyketide–nonribosomal peptide hybrid macrolactone from extreme thermophilic fungi. J Am Chem Soc 142:1957–1965. https://doi.org/10.1021/jacs.9b11410
Zhao Y-R, Li H-M, Zhu M, Li J, Ma T, Huo Q, Hong Y-S, Wu C-Z (2018) Non-benzoquinone geldanamycin analog, WK-88-1, induces apoptosis in human breast cancer cell lines. J Microbiol Biotechnol 28:542–550. https://doi.org/10.4014/jmb.1710.10063
Zilinyi R, Czompa A, Czegledi A, Gajtko A, Pituk D, Lekli I, Tosaki A (2018) The cardioprotective effect of metformin in doxorubicin-induced cardiotoxicity: the role of autophagy. Molecules 23:1184. https://doi.org/10.3390/molecules23051184
Author information
Authors and Affiliations
Contributions
R.K. and A.S. share equal contribution to the manuscript for their efforts in literature collection, methodology, drafting of the article, data analysis, and critical revision of the article. D.S. conceived the paper and contributed towards the final drafting and editing of the manuscript. All authors read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kapoor, R., Saini, A. & Sharma, D. Indispensable role of microbes in anticancer drugs and discovery trends. Appl Microbiol Biotechnol 106, 4885–4906 (2022). https://doi.org/10.1007/s00253-022-12046-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-022-12046-2